KOSUNI CRYPTO
Korea's Crypto Pulse, in English
$BTC $ETH $XRP $SOL $DOGE
Regulation
Neutral

Injective CEO Says US INJ ETF Could Launch This Year

Published October 5, 2026 9:32 PM · 6 views $INJ
Injective CEO Says US INJ ETF Could Launch This Year

Injective (INJ) co-founder and CEO Eric Chen has forecasted that an INJ-based exchange-traded fund (ETF) could be launched in the U.S. before 2027.

According to cryptocurrency media The Block, Chen stated in a recent interview that while he cannot specify an exact timeline, 2027 is "a bit too far," and progress is moving much faster than he initially expected.

Currently, two INJ-related ETF applications have been submitted to the U.S. Securities and Exchange Commission (SEC): the 21Shares Injective ETF and Canary Staked INJ ETF. Both fund managers first filed their applications last year and resubmitted amended S-1 registration statements in September.

Injective is also expanding its institutional presence in the U.S. Injective Institutional Services recently obtained SEC registration as a transfer agent, with CEO Chen noting that this is just the beginning, as further licensing efforts are underway.

Last month, Injective rolled out an upgrade called 'Meridian' to enhance institutional features. Chen explained that Meridian enables institutions to transition from pilot testing to live services for on-chain tokenization, asset issuance, and collateral use.

In Europe, Injective has completed submitting its MiCA whitepaper for the virtual asset market law (MiCA). The project is also collaborating with licensed financial institutions in payment and tokenization sectors.

Korean Source

This article is an English localization of a Korean-language crypto news report. Original headline: 인젝티브 CEO "美 INJ ETF, 올해 출시될 수도"